But the Rowan University project had been turning for quite some time.
"The genesis of this goes back before the pandemic," Annette Reboli, dean of Rowan's Cooper Medical School, said of the venture. "We knew this was coming. There had been plenty of publicity around the topic both in New Jersey and with other states doing legalization, and so we're forging ahead with something we believe will serve the public at large."
Rowan, through its institute, has identified three focus groups it sees as vital in relation to the marijuana industry:
Center for Cannabinoid Science & Therapeutics — will, in part, study cannabinoid compounds and how they can impact a person's health and well-being.